BI
BioLoomics, Inc.
SEC filingOther · Boulder, CO
Amount raised$450Ksold at filing
Total offering$2M$1.6M still open
Investors in the raise5count reported to the SEC
FiledNov 10, 2025first sale Aug 11, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nicholas A SaccomanoDirector
Douglas A ChapnickExecutive Officer, Director, Promoter
Joel A DudleyDirector
Executive officers, directors and promoters as listed on the Form D.